US drug pricing plan puts Japan at risk of losing access to new medicines

In Japan, the prices of new drugs are 61% lower than the U.S. at the time of launch. (Source photos by Nikkei)

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.